Bruker Corporation announces novel magnet technology and analytical solutions to support broad adoption of nuclear magnetic resonance, NMR, in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies, PAT.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: